BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25878173)

  • 1. Antiphospholipid Antibodies and Procoagulant Profile in Tunisians With Inflammatory Bowel Diseases.
    Kraiem I; Hadhri S; Ben Rejeb M; Ifa L; Jmaa A; Ajmi S; Skouri H
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):734-742. PubMed ID: 25878173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
    Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of antiphospholipid antibodies in primary biliary cirrhosis.
    Mankaï A; Manoubi W; Ghozzi M; Melayah S; Sakly W; Ghedira I
    J Clin Lab Anal; 2015 Jan; 29(1):32-6. PubMed ID: 24687920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodialysis duration, human platelet antigen HPA-3 and IgA isotype of anti-β2glycoprotein I antibodies are associated with native arteriovenous fistula failure in Tunisian hemodialysis patients.
    Hadhri S; Rejeb MB; Belarbia A; Achour A; Skouri H
    Thromb Res; 2013 May; 131(5):e202-9. PubMed ID: 23538147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA is the predominant isotype of anti-β2 glycoprotein I antibodies in rheumatoid arthritis.
    Melayah S; Changuel M; Mankaï A; Ghedira I
    J Clin Lab Anal; 2020 Jun; 34(6):e23217. PubMed ID: 31967351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of anti-β2glycoprotein I IgA antibodies to the diagnosis of anti-phospholipid syndrome: potential interest of target domains to discriminate thrombotic and non-thrombotic patients.
    Despierres L; Beziane A; Kaplanski G; Granel B; Serratrice J; Cohen W; Bretelle F; Rossi P; Morange PE; Weiller PJ; Robert Harlé J; Bongrand P; Bardin N
    Rheumatology (Oxford); 2014 Jul; 53(7):1215-8. PubMed ID: 24599915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis.
    Lakos G; Teodorescu M
    Lupus; 2011 May; 20(6):614-9. PubMed ID: 21436214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease.
    Mankaï A; Achour A; Thabet Y; Manoubia W; Sakly W; Ghedira I
    Pathol Biol (Paris); 2012 Oct; 60(5):291-5. PubMed ID: 21839587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease.
    Alkim H; Ayaz S; Alkim C; Ulker A; Sahin B
    Clin Appl Thromb Hemost; 2011; 17(6):600-4. PubMed ID: 21593018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L; Decavele AS; Schouwers S; Devreese K
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive screening analysis of antiphospholipid antibodies in Indian women with fetal loss.
    Vora S; Shetty S; Salvi V; Satoskar P; Ghosh K
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):136-40. PubMed ID: 17644242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody profiles for the diagnosis of antiphospholipid syndrome.
    Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
    Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to anionic phospholipids and cofactors in kala-azar. Comparative study with malaria, toxoplasmosis and "autoimmune diseases".
    Skouri H; Gandouz R; Kraiem I; Harrabi I; Ben Said M
    Clin Exp Rheumatol; 2008; 26(5):894-902. PubMed ID: 19032825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
    Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.